The global skin antiseptic products market size is expected to reach USD 326.75 million by 2026 registering a CAGR of 6.9%, according to a new report by Grand View Research, Inc. Rising incidences of Hospital-Acquired Infections (HAIs) and increasing usage of surgical units and endoscope reprocesses are the key driving factors for the market. Rising number of surgeries being performed is also expected to drive the market over the forecast period. According to the Agency for Healthcare Research and Quality (AHRQ), 17.2 million hospital visits included surgical procedures in U.S. in 2014.
Demand for alcohol antiseptics for pre-injection and pre-operative skin preparations is increasing significantly. In addition, alcohol antiseptics are being used as a base along with various formulations, such as iodine and chlorhexidine. Exceptional properties of alcohol-based antiseptics for surgical purpose is driving the market. Growing awareness regarding the benefits of skin antiseptic products and increasing R&D funding are creating opportunities for market entrants. Moreover, various programs being conducted by manufacturers and governments regarding to boost the awareness about the importance of using skin antiseptic products is also expected to contribute significantly to the skin antiseptic product market growth.
Further key findings from the study suggest:
- North America led the global market in 2018 and is anticipated to maintain its position throughout the forecast years owing to rise in number of surgeries being performed and presence of key companies in the region
- Octenidine is anticipated to be the fastest-growing formulation segment over the forecast period. Octenidine is an internal substitute for chlorhexidine and iodine
- Injection segment led the market in 2018 owing to rise in incidence of spinal injuries and usage of skin antiseptic products for pre-injection skin preparation
- Wipes segment is expected to witness the fastest growth over the forecast period as wipes are easy use and possess lesser risk of contamination
- Key companies in the skin antiseptic product market are BD, 3M, Ecolab, Schülke & Mayr GmbH, Sage Products LLC, Johnson & Johnson, and B. Braun Melsungen AG
Grand View Research has segmented the global skin antiseptic product market on the basis of formulations, type, application, and region:
Skin Antiseptic Products Formulations Outlook (Revenue, USD Million, 2015 - 2026)
- Alcohols
- Chlorhexidine
- Iodine
- Octenidine
- Others
Skin Antiseptic Products Skin AntisepticProducts Type Outlook (Revenue, USD Million, 2015 - 2026)
- Solutions
- Swab Sticks
- Wipes
Skin Antiseptic Products Application Outlook (Revenue, USD Million, 2015 - 2026)
- Surgeries
- Spinal
- Joint
- Other
- Injections
- Spinal
- Joint
- Other
Skin Antiseptic Products Regional Outlook (Revenue, USD Million, 2015 - 2026)
- North America
- US.
- Canada
- Europe
- UK.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment